2026
Percutaneous Endobiliary Cryobiopsy in Biliary Obstruction: Randomised Study (BICRYOB)
ROHAN, Tomáš; Barbora HANŽLOVÁ; Peter MATKULČÍK; Jakub VLAŽNÝ; Dávid SAID et al.Základní údaje
Originální název
Percutaneous Endobiliary Cryobiopsy in Biliary Obstruction: Randomised Study (BICRYOB)
Autoři
ROHAN, Tomáš; Barbora HANŽLOVÁ; Peter MATKULČÍK; Jakub VLAŽNÝ; Dávid SAID; Marek DOSTÁL a Tomáš ANDRAŠINA
Vydání
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY, NEW YORK, SPRINGER, 2026, 0174-1551
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30224 Radiology, nuclear medicine and medical imaging
Stát vydavatele
Rakousko
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.900 v roce 2024
Označené pro přenos do RIV
Ano
Organizační jednotka
Lékařská fakulta
UT WoS
EID Scopus
Klíčová slova anglicky
Cryobiopsy; Biliary obstruction; Randomised study
Štítky
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 3. 3. 2026 13:33, Mgr. Tereza Miškechová
Anotace
V originále
Design and Purpose To assess feasibility and technical outcome of endobiliary cryobiopsy compared to standard technique of endobiliary forceps biopsy in randomized study. Material and Methods This prospective study included 22 patients with indeterminate biliary stenosis. All patients underwent percutaneous endoluminal forceps biopsy and endoluminal cryobiopsy under the fluoroscopy guidance. The order of sample collection was randomized. The technical feasibility of cryobiopsy and the rate of serious complications were analyzed. Sensitivity in detecting malignancy, sample weight, total sample area, sample area without artifacts, and sample quality (five-point Likert scale) assessed by two certified pathologists were compared between both methods. Results No CTCAE (Common Terminology Criteria for Adverse Events) v.5 grade 3-4 complications were reported during or after the procedure, and cryobiopsy was technically feasible in all patients. Three of 22 patients were excluded from the analysis. A total of 232 samples were collected (112 forceps biopsy, 120 cryobiopsy). Cryobiopsy and forceps biopsy respectively detected carcinoma in 15/19 patients and 11/19 patients in total yielding positive diagnostic histology for malignancy in 79% and 58% (p = 0.11). Among the 17 patients ultimately diagnosed with malignancy, sensitivity for cryobiopsy and forceps biopsy was 88% and 65%, respectively and overall accuracy was 89% (17/19) or cryobiopsy and 68% (13/19) for forceps biopsy. Cryobiopsy provided significantly larger total and artifact-free sample areas (median 2.66 vs 0.84 mm(2) and 1.77 vs 0.18 mm(2), respectively; p < 0.001), fewer non-evaluable samples (8% vs 40%; p < 0,001), and a significantly greater median weight (7.6 vs 3.6 mg; p < 0.001). Cryobiopsy samples demonstrated markedly superior quality assessments (median Likert scale value 4 vs 2, p < 0.001; Likert > 2 in 83% vs 38%, p < 0.001). Conclusion Cryobiopsy in the biliary tract appears to be a safe and feasible technique, allowing more representative histological samples to be obtained compared with forceps biopsy.
Návaznosti
| MUNI/A/1755/2024, interní kód MU |
| ||
| NU21-08-00561, projekt VaV |
|